Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Top Cited Papers
Open Access
- 23 September 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 20 (12), 1390-1400
- https://doi.org/10.1016/s1473-3099(20)30634-4
Abstract
No abstract availableFunding Information
- Kennedy Trust for Rheumatology Research (number 1097737)
- Wellcome Trust (110110/15/Z/15)
This publication has 20 references indexed in Scilit:
- Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, IdahoJournal of Clinical Microbiology, 2020
- A serological assay to detect SARS-CoV-2 seroconversion in humansNature Medicine, 2020
- Developing antibody tests for SARS-CoV-2The Lancet, 2020
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal KenyaThe Journal of Infectious Diseases, 2018
- Cohort Profile: The Oxford BiobankInternational Journal of Epidemiology, 2017
- MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Emerging Infectious Diseases, 2017
- Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significanceRespirology, 2006
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990
- The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: Evidence of heterogeneity among 229E‐related strainsJournal of Medical Virology, 1984